Pharmacological Therapeutic Strategies and Drug Delivery for Craniofacial District
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 9057
Special Issue Editor
Interests: temporomandibular disorders; TED; temporomandibular joint; orofacial pain; dentistry; telemedicine; tele dentistry; implant; prosthesis; oral surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This thematic issue aims to provide an update regarding new advances and knowledge in drug delivery and pharmacological therapeutic strategies for oral applications, including in vivo and in vitro studies. The topic includes different biomedical sectors and involves pathologies associated with pain and dysfunction in the orofacial district, providing a global overview of oral dentistry from innovative biomedical techniques to the molecular aspects of oral and periodontal disease pathogenesis. Updates in biomedical technologies to improve the prevention and treatment of oral health conditions, focusing on drug delivery and biotechnological applications of active compounds in the cranio-maxillofacial district, are of interest.
Dr. Giuseppe Minervini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- craniofacial district
- natural products
- drug delivery
- TMD
- oral surgery
- oral cavity
- temporomandibular disorder
- oral pathology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.